Evaluation of PCR Primers for Early Diagnosis of Cytomegalovirus Infection following Liver Transplantation
- 1 February 1998
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 36 (2) , 526-530
- https://doi.org/10.1128/jcm.36.2.526-530.1998
Abstract
The availability of microbiologic methods that detect early replication of cytomegalovirus (CMV) posttransplantation will enhance the process of initiating preemptive antiviral therapy prior to the appearance of CMV disease. Using PCR techniques we sought to determine which region of the CMV genome present in peripheral blood leukocytes (PBLs) or serum provides the highest sensitivity for the detection of CMV posttransplantation. Blood samples were prospectively collected weekly for at least 8 weeks from a cohort of 21 consecutive liver transplant recipients not receiving anti-CMV prophylaxis. Results of PCR assays were correlated with recovery of CMV in cell cultures and histopathological findings from biopsy specimens of infected organs to assess clinical symptomatic infection. Of 148 specimens, primer pairs directed to the Hin dIII-X fragment region of CMV detected target DNA with a 94% sensitivity, compared to an 87% sensitivity with primer pairs directed to Eco RI fragment D, 32% sensitivity with primer pairs directed to the immediate-early antigen 1 gene (IEA1 gene), and 20% sensitivity with primer pairs directed to the major immediate-early (MIE) gene. The performance characteristics in terms of the sensitivity of primers for amplifying CMV DNA associated with symptomatic infection ranged from 100% ( Hin dIII-X) to 20% (MIE gene); however, specificity was inversely related ( Hin dIII-X, 45%; MIE gene, 91%) to primers directed to these gene targets. When Hin dIII-X and Eco RI-D primer sets were used, CMV DNA from PBLs was a more sensitive target than CMV DNA from serum for the early detection of symptomatic CMV infection (17 versus 12 days). Importantly, CMV DNA was not detected in five patients with no evidence of this viral infection. In conclusion, primers directed to the Hin dIII-X fragment region were the most optimal for the early detection of CMV DNA in PBLs and sera from symptomatic liver transplant recipients.Keywords
This publication has 24 references indexed in Scilit:
- Definitions of cytomegalovirus disease after heart transplantation: Antigenemia as a marker for antiviral therapyTransplant International, 1996
- Time to Detection of Cytomegalovirus (CMV) DNA in Blood Leukocytes Is a Predictor for the Development of CMV Disease in CMV-Seronegative Recipients of Allografts from CMV-Seropositive Donors following Liver TransplantationThe Journal of Infectious Diseases, 1996
- Definitions of cytomegalovirus disease after heart transplantation: Antigenemia as a marker for antiviral therapyTransplant International, 1996
- SIGNIFICANCE OF HUMAN CYTOMEGALOVIRUS DNA DETECTION IN IMMUNOCOMPROMISED HEART TRANSPLANT PATIENTSTransplantation, 1996
- Clinical evaluation in organ transplant patients of a polymerase chain reaction test for CMV DNA applied on white blood cells and serumTransplant International, 1994
- Clinical evaluation in organ transplant patients of a polymerase chain reaction test for CMV DNA applied on white blood cells and serumTransplant International, 1994
- EARLY DIAGNOSIS OF HUMAN CYTOMEGALOVIRUS DISEASE IN TRANSPLANT RECIPIENTS BY DNA AMPLIFICATION IN PLASMATransplantation, 1993
- THE CORRELATION BETWEEN SYMPTOMATIC CMV INFECTION AND CMV ANTIGENEMIA IN HEART ALLOGRAFT RECIPIENTSTransplantation, 1993
- Monitoring of Human Cytomegalovirus Infections and Ganciclovir Treatment in Heart Transplant Recipients by Determination of Viremia, Antigenemia, and DNAemiaThe Journal of Infectious Diseases, 1991
- RAPID DETECTION OF HUMAN CYTOMEGALOVIRUS DNA IN PERIPHERAL BLOOD LEUKOCYTES OF VIREMIC TRANSPLANT RECIPIENTS BY THE POLYMERASE CHAIN REACTIONTransplantation, 1989